Recent Progress in the Use of Glucagon and Glucagon Receptor Antagonists in the Treatment of Diabetes Mellitus

Open Medicinal Chemistry Journal - United Arab Emirates
doi 10.2174/1874104501408010028
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

In Silico Identification of Novel Glucagon Receptor Antagonist for the Treatment of Type 2 Diabetes Mellitus

Enzyme Engineering
2015English

Use of Glucagon in the Treatment of Pancreatitis

BMJ
1971English

High Potency Antagonists of the Pancreatic Glucagon-Like Peptide-1 Receptor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1997English

Glucagon-Like Peptide Analogues for Type 2 Diabetes Mellitus

2007English

Antibodies Against Specific Extracellular Epitopes of the Glucagon Receptor Block Glucagon Binding.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1996English

Perfect Normalization of Exaggerated Glucagon Responses in Noninsulin-Dependent and Insulin-Dependent Diabetes Mellitus

Folia Endocrinologica Japonica
1983English

Review of Glucagon‐Like Peptide‐1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus in Patients With Chronic Kidney Disease and Their Renal Effects

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2019English

Glucagon Is the Key Factor in the Development of Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Correction To: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features

Clinical Drug Investigation
MedicinePharmacology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy